Progressive Axonal Dysfunction Precedes Development of Neuropathy in Type 2 Diabetes

Diabetes, 05/11/2012

These results suggest a spectrum of excitability abnormalities in patients with diabetes and that early axonal dysfunction may be detected prior to the development of neuropathy. As progressive changes in excitability parameters correlated to neuropathy severity, excitability testing may provide a biomarker of the early development and severity of diabetic neuropathy, providing insights into the pathophysiological mechanisms producing axonal dysfunction.

Print Article Summary Cat 2 CME Report